Description
Paclitaxel is a chemotherapeutic tumor drug used to treat metastatic breast cancer after failure of combination chemotherapy or relapse within 6 months after adjuvant chemotherapy. Its product, developed by Abolis, was approved by the FDA in 2005 and was approved in China in 2008. By 2020, there are 34 manufacturers in the Chinese Paclitaxel market, with Nanjing Luye Pharmaceutical Co., Ltd. accounting for the most market share in the Chinese Paclitaxel market.
According to CRI analysis, the sales of Paclitaxel in the Chinese market increased year by year from 2016 to 2019. Among them, the annual growth rate of 40.86% was the highest in 2019, from CNY2.168 billion in 2018 to CNY3.053 billion in 2019. In 2020, the hospital's overall diagnosis and treatment services were impacted by the Covid-19 epidemic, and Paclitaxel was included in the second batch of national organization drug procurement due to more than 3 manufacturers. With the sharp price reduction in centralized procurement, Paclitaxel sales have declined with a growth rate of -18.64%. The CAGR of Paclitaxel sales in the Chinese market from 2016 to 2020 was 7.16%.
CRI analyzes that the Paclitaxel sales in China will increase steadily with the increase in breast cancer patients from 2021 to 2025. In 2020, the number of new cases of breast cancer worldwide reached 2.26 million, and breast cancer is the most commonly diagnosed cancer, overtaking lung cancer. Therefore, the sales and sales volume of Paclitaxel for the treatment of breast cancer will increase accordingly with the increase in the number of patients diagnosed. Furthermore, Paclitaxel will be included in the National Drug Price Negotiation in 2021, and then its sales will keep a continuous rise. In addition, the effective alleviation of the Covid-19 epidemic will lead to a recovery growth in the sales of Paclitaxel.
Topics Covered:
-The impact of COVID-19 on China's Paclitaxel market
- Sales value of China's Paclitaxel 2016-2020
- Competitive landscape of China's Paclitaxel market
- Prices of Paclitaxel in China
- Prices of Paclitaxel in China by regions and manufacturers
- Analysis of factors affecting the development of China's Paclitaxel market
- Prospect of China's Paclitaxel market from 2021 to 2025
Investigation Report on China's Paclitaxel Market 2021-2025
Table of Contents
1 Relevant Concepts of Paclitaxel
1.1 Indications for Paclitaxel
1.2 Development of Paclitaxel in China
1.3 Governmental Approval of Paclitaxel in China
1.4 The Impact of COVID-19 on Paclitaxel sales in China
2 Sales of Paclitaxel in China, 2016-2020
2.1 Sales Value of Paclitaxel
2.1.1 Overall Sales Value
2.1.2 Sales Value by Regions
2.2 Sales Volume of Paclitaxel
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Paclitaxel by Dosage Form in China, 2016-2020
2.3.1 Liposome injection
2.3.2 Injection (nanoparticle albumin-bound)
2.3.3 Injection
2.3.4 Analysis of Other Dosage Forms
3 Analysis of Major Paclitaxel Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Paclitaxel Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Nanjing Luye Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of LIPOSOME (Nanjing Luye Pharmaceutical Co., Ltd.'s Paclitaxel) in China
3.3 CSPC Ouyi Pharmaceutical Group Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Keaili (CSPC Ouyi Pharmaceutical Group Co., Ltd.'s Paclitaxel) in China
3.4 Jiangsu Hengrui Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Aiyue (Jiangsu Hengrui Pharmaceutical Co., Ltd.'s Paclitaxel) in China
3.5 Hospira Australia Pty Ltd
3.5.1 Enterprise Profile
3.5.2 Sales of Paclitaxel (Hospira Australia Pty Ltd's Paclitaxel) in China
3.6 Beistol-Myers Squibb S.r.l.
3.6.1 Enterprise Profile
3.6.2 Sales of TAXOL (Beistol-Myers Squibb S.r.l.'s Paclitaxel) in China
4 Prices of Paclitaxel for Different Manufacturers in China, 2020-2021
4.1 Nanjing Luye Pharmaceutical Co., Ltd. (LIPOSOME)
4.2 CSPC Ouyi Pharmaceutical Group Co., Ltd. (Keaili)
4.3 Jiangsu Hengrui Pharmaceutical Co., Ltd. (Aiyue)
4.4 Hospira Australia Pty Ltd (ANZATAX)
4.5 Beistol-Myers Squibb S.r.l.?TAXOL?
5 Prospect of Chinese Paclitaxel Market, 2021-2025
5.1 Influential Factors of Chinese Paclitaxel Market Development
5.1.1 The Impact of COVID-19 on Chinese Paclitaxel Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Paclitaxel Liposome Injection Registration in China
Chart Patent Information About Paclitaxel (Nanoparticle Albumin-bound) Injection Registration in China
Chart Patent Information About Paclitaxel Injection Registration in China
Chart Sales Value of Paclitaxel Liposome Injection over the World
Chart Sales Value of Paclitaxel Injection (Nanoparticle Albumin-bound) over the World
Chart Sales Value of Paclitaxel Injection over the World
Chart Sales Value of Paclitaxel Liposome Injection in China, 2016-2020
Chart Sales Value of Paclitaxel Injection (Nanoparticle Albumin-bound) in China, 2016-2020
Chart Sales Value of Paclitaxel Injection in China, 2016-2020
Chart Sales Value of Paclitaxel Liposome Injection in China by Regions, 2016-2020
Chart Sales Value of Paclitaxel Injection (Nanoparticle Albumin-bound) in China by Regions, 2016-2020
Chart Sales Value of Paclitaxel Injection in China by Regions, 2016-2020
Chart Sales Volume of Paclitaxel Liposome Injection in China, 2016-2020
Chart Sales Volume of Paclitaxel Injection (Nanoparticle Albumin-bound) in China, 2016-2020
Chart Sales Volume of Paclitaxel Injection in China, 2016-2020
Chart Sales Volume of Paclitaxel Liposome Injection in China by Regions, 2016-2020
Chart Sales Volume of Paclitaxel Injection (Nanoparticle Albumin-bound) in China by Regions, 2016-2020
Chart Sales Volume of Paclitaxel Injection in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Paclitaxel Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Paclitaxel Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Injection Manufacturers in China, 2016-2020
Chart Sales Value and Volume of LIPOSOME in China, 2016-2020
Chart Sales Value and Volume of Keaili in China, 2016-2020
Chart Sales Value and Volume of Aiyue in China, 2016-2020
Chart Sales Value and Volume of ANZATAX in China, 2016-2020
Chart Sales Value and Volume of TAXOL in China, 2016-2020
Chart Referential Prices of LIPOSOME in China by Regions, 2020-2021
Chart Referential Prices of Keaili in China by Regions, 2020-2021
Chart Referential Prices of Aiyue in China by Regions, 2020-2021
Chart Referential Prices of ANZATAX in China by Regions, 2020-2021
Chart Referential Prices of TAXOL in China by Regions, 2020-2021
Chart Forecast on Sales Value of Liposome Injection in China, 2021-2025
Chart Forecast on Sales Value of Injection (Nanoparticle Albumin-bound) in China, 2021-2025
Chart Forecast on Sales Value of Injection in China, 2021-2025
Chart Forecast on Sales Volume of Liposome Injection in China, 2021-2025
Chart Forecast on Sales Volume of Injection (Nanoparticle Albumin-bound) in China, 2021-2025
Chart Forecast on Sales Volume of Injection in China, 2021-2025
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
